Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2044939 | 0.81 | ESR2 (0.49) | OPRM1 | |
| SCHEMBL8101425 | 0.77 | OPRM1 (0.50) | MAPK1SMN1; SMN2OPRM1DRD4 | |
| SCHEMBL9858405 | 0.74 | — | — | |
| SCHEMBL11572399 | 0.73 | OPRL1 (0.52) | MAPK1SMN1; SMN2OPRM1DRD4 | |
| SCHEMBL11766751 | 0.73 | HTR2A (0.45) | MAPK1SMN1; SMN2OPRM1DRD4 | |
| SCHEMBL11763463 | 0.73 | MAPK1 (0.44) | MAPK1SMN1; SMN2OPRM1DRD4 | |
| SCHEMBL9065813 | 0.73 | ESR2 (0.42) | MAPK1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL11569798 | 0.72 | OPRL1 (0.50) | MAPK1SMN1; SMN2 | |
| SCHEMBL9066385 | 0.71 | ACHE (0.53) | OPRM1 | |
| SCHEMBL3359965 | 0.70 | MAPK1 (0.33) | MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101309753-B | Carbonylation of ethylenically unsaturated compounds | LUCITE INT UK LTD | 2013-01-30 | — | — | CN | claimed |
| CN-101309753-A | Carbonylation of ethylenically unsaturated compounds | LUCITE INT UK LTD (GB) | 2008-11-19 | — | — | CN | claimed |
| EP-1957198-A1 | CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | Lucite International UK Limited (GB) | 2008-08-20 | — | — | EP | claimed |
| WO-2007057640-A1 | CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2007-05-24 | — | — | WO | claimed |
| EP-2794548-B1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | LUCITE INT UK LTD (GB) | 2019-05-15 | — | — | EP | disclosed |
| EP-2794548-A1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | Lucite International UK Limited (GB) | 2014-10-29 | — | — | EP | disclosed |
| WO-2013093472-A1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | LUCITE INTERNATIONAL UK LIMITED (GB) | 2013-06-27 | — | — | WO | disclosed |
| US-8445711-B2 | Metal complexes | LUCITE INTERNATIONAL UK LIMITED (GB) | 2013-05-21 | — | — | US | disclosed |
| CN-101309753-B | Carbonylation of ethylenically unsaturated compounds | LUCITE INT UK LTD | 2013-01-30 | — | — | CN | disclosed |
| US-20120309613-A1 | CARBONYLATION PROCESS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2012-12-06 | — | — | US | disclosed |
| EP-2513031-A1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | Lucite International UK Limited (GB) | 2012-10-24 | — | — | EP | disclosed |
| CN-102740972-A | Improved carbonylation process | LUCITE INT UK LTD | 2012-10-17 | — | — | CN | disclosed |
| US-20100022799-A1 | CARBONYLATION OF CONJUGATED DIENES | LUCITE INTERNATIONAL UK LIMITED (GB) | 2010-01-28 | — | — | US | disclosed |
| US-20090312561-A1 | METAL COMPLEXES | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-12-17 | — | — | US | disclosed |
| EP-2094635-A1 | CARBONYLATION OF CONJUGATED DIENES | Lucite International UK Limited (GB) | 2009-09-02 | — | — | EP | disclosed |
| WO-2009010782-A1 | A PROCESS FOR THE CARBONYLATION OF AN ETHYLENICALLY UNSATURATED COMPOUND AND A CATALYST SYSTEM | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-01-22 | — | — | WO | disclosed |
| CN-101309753-A | Carbonylation of ethylenically unsaturated compounds | LUCITE INT UK LTD (GB) | 2008-11-19 | — | — | CN | disclosed |
| EP-1957198-A1 | CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | Lucite International UK Limited (GB) | 2008-08-20 | — | — | EP | disclosed |
| WO-2008075108-A1 | CARBONYLATION OF CONJUGATED DIENES | LUCITE INTERNATIONAL UK LIMITED (GB) | 2008-06-26 | — | — | WO | disclosed |
| WO-2007057640-A1 | CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2007-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022799-A1 | CARBONYLATION OF CONJUGATED DIENES | CBR3, CBR1, CA5B | MAPK1 1670/4885SMN1; SMN2 2256/4885OPRM1 2383/4885 |
| US-20090312561-A1 | METAL COMPLEXES | MLX, PICALM, AP2M1 | MAPK1 2355/4885SMN1; SMN2 2999/4885OPRM1 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.